Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vytrus Biotech develops and commercializes natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology. The company has launched over a dozen ingredients globally, with clinical validation for efficacy in skin rejuvenation, hydration, microbiome modulation, hair growth stimulation, wound healing support, and more. Their actives are distributed in over sixty countries. Recent innovations include plant exosome-based products and patented wound-healing applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vytrus Biotech.